| Medicare CGS | Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis (59529) | 2025-08-01 |
| Medicare NGS | Billing and Coding: Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases (56793) | 2025-08-01 |
| Meridian Illinois Medicaid Clinical | Apremilast | 2025-07-31 |
| Meridian Illinois Medicaid Clinical | Golimumab (Simponi, Simponi Aria) | 2025-07-31 |
| Meridian Illinois Medicaid Clinical | Infliximab, Infliximab-dyyb, Infliximab-abda | 2025-07-31 |
| Meridian Illinois Medicaid Clinical | Mirikizumab-mrkz (Omvoh) | 2025-07-31 |
| Medicare CGS | Process for Determining Self-Administered Drug Exclusions – Medical Policy Article (52535) | 2025-07-31 |
| Medicare CGS | Billing and Coding: MDS FISH (56926) | 2025-07-31 |
| Medicare CGS | Billing and Coding: Venipuncture Necessitating Physician–s Skill for Specimen Collection – Supplemental Instructions Article (52470) | 2025-07-29 |
| Medicare CGS | Billing and Coding: Rezum– System for Benign Prostatic (56083) | 2025-07-29 |